Britannia Life Sciences Inc.
BLSIF
$0.06
$0.03100.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.81M | 5.80M | 5.70M | 5.12M | 5.08M |
| Total Depreciation and Amortization | 34.10K | 33.50K | 44.40K | 43.90K | 43.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.22M | -9.20M | -8.83M | -7.95M | -7.70M |
| Change in Net Operating Assets | -2.17M | -255.70K | -10.80K | 141.30K | 770.80K |
| Cash from Operations | -1.55M | -3.63M | -3.10M | -2.65M | -1.81M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.81M | 3.57M | 3.50M | 7.06M | 7.18M |
| Cash from Investing | -3.81M | 3.57M | 3.50M | 7.06M | 7.18M |
| Total Debt Issued | -- | 958.60K | 909.10K | 1.68M | 1.68M |
| Total Debt Repaid | -84.60K | -1.09M | -1.12M | -1.11M | -1.10M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -186.20K | -737.90K | -1.29M | -1.79M |
| Cash from Financing | -61.20K | -226.40K | -672.20K | -508.60K | -867.00K |
| Foreign Exchange rate Adjustments | 300.00 | -10.70K | -11.80K | 18.10K | 31.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.42M | -289.50K | -280.10K | 3.92M | 4.54M |